Thursday, November 30, 2023

The Future of Healthcare Integration: Healthcare Interoperability Solutions Market

 Growth in Healthcare Interoperability Solutions Market is driven by the increasing demand for efficient and cost-effictive healthcare delivery,  government initiatives towards improving the healthcare interoperability. However, the lack of true interoperability among electric systems, financial burden and technical difficulties in building and operations are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period. The base year considered for the study is 2021, while, the forecast period is 2022 to 2027.

The report Healthcare Interoperability Solutions Market is projected to reach USD 6.2 billion by 2027 from USD 3.4 billion in 2022, at a CAGR of 12.9% during the forecast period.

 

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17705847

KEY MARKET DYNAMICS 

           1 DRIVERS

                   1.1 Increasing demand for efficient and cost-effective healthcare delivery

                   1.2 Government initiatives and regulations to enhance patient care and safety

                   1.3 Emergence of new medical technologies

                   1.4 Growing adoption of electronic health records

           2 RESTRAINTS

                   2.1 Lack of accurate interoperability solutions across healthcare supply chain

                   2.2 Lack of standards and protocols in IT businesses

                   2.3 Use of outdated legacy systems in hospitals and clinic chains

          3 OPPORTUNITIES

                   3.1 Growing markets for healthcare interoperability solutions in developing countries

                   3.2 Advancements in software technology for real-time data exchange

          4 CHALLENGES

                   4.1 Increasing complexity due to lack of consistent data

                   4.2 Shortage of skilled healthcare IT professionals

                   4.3 Patient data security and privacy concerns in healthcare industry

 

Market Segmentation:

·         On the basis of type: the services segment accounted for the largest share. The large share of this segment can be attributed to the advantages offered by the services such as installation, equipment updates or traditional licensing management are not required in case of services.

·         Based on end user: the healthcare providers segment is expected to register the highest CAGR during the forecast period. The growing geriatric population leading to the increasing hospital admissions is contributing to the growth of this segment.

 

Regional Analysis:

North America accounted for the largest share of the healthcare interoperability solutions market in 2021, followed by Europe and Asia Pacific. The rising demand for value-based healthcare, the need to reduce the increasing healthcare costs, and the implementation of favorable government initiatives & regulations in the region are the key factors responsible for the large share of North America in the healthcare interoperability solutions market.

Recent Developments

·         In November 2022, Nextge Healthcare (US) acquired TSI Healthcare (US) to expand its presence in key specialties, including rheumatology, pulmonology, and cardiology.

·         In October 2022, Lyniate (US) partnered with CyncHealth (US) to help healthcare providers and health networks, payers, and public health departments power more meaningful data exchange.

·         In September 2022, Lyniate (US) partnered with BrightInsight (US) to improve Information Exchange for Regulated Digital Health Solutions Built on the BrightInsight Platform.

·         In July 2022, Intersystem Corporation (US) partnered with Bedfordshire Hospitals NHS Foundation Trust to develop a new shared health and care record, which is being rolled out across Bedfordshire and Luton.

Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=17705847

Top Key Players: -

Some of the prominent players in this market are Cerner Corporation (US), Epic Systems Corporation (US), Infor, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), IBM Watson Health (US), Lyniate (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), and Medical Information Technology, Inc. (US), iNTERFACEWARE (Canada), OSP Labs (US), ViSolve, Inc. (US), Jitterbit (US), Virtusa Corp. (US), and Summit Healthcare Services, Inc. (US).

Conclusion: -

In conclusion, the Healthcare Interoperability Solutions Market is poised for significant growth as healthcare organizations strive to improve patient outcomes through seamless data exchange and better care coordination. With advances in technology and increasing demand for interoperable systems, healthcare providers can expect to see increased efficiency, accuracy, and quality of care. The benefits of healthcare interoperability are far-reaching and can impact not only individual patient outcomes, but also the overall performance and sustainability of the healthcare system. The future of healthcare is centered on seamless integration and interoperability, and the Healthcare Interoperability Solutions Market is at the forefront of this revolution.

Wednesday, November 29, 2023

Urinary Catheters Market - Growth Drivers & Opportunities | MarketsandMarkets

 The growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario are the major factors driving the growth of this market.

The global urinary catheters market size is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132934629

Scope of the Report

This report categorizes the urinary catheters market into the following segments and subsegments:

By Product

  • Indwelling Catheters
  • Intermittent Catheters
  • External Catheters

By Type

  • Coated Catheters
  • Uncoated Catheters 

By Usage

  • Male Urinary Catheters
  • Female Urinary Catheters 

By Application

  • Urinary Incontinence
  • General Surgery
  • Benign Prostatic Hyperplasia
  • Other Applications (spinal cord injuries, spina bifida, multiple sclerosis, and Parkinson’s disease)

By End-User

  • Hospitals
  • Long-Term Care Facilities
  • Other End Users (emergency clinics and physicians’ offices)

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World



Market Segmentation :

Based on products, the global market is segmented into indwelling catheters, intermittent catheters, and external catheters. Indwelling catheters accounted for the largest share of the market in 2019. These catheters are also widely used in high-acuity patient units, with critical care and intensive care units registering the highest usage of indwelling catheters. Growth in this market is largely driven by the cost-efficiency and high availability of indwelling catheters in the market.

By catheter type, the global market is segmented into coated and uncoated catheters. Coated catheters accounted for the largest share of the market in 2019. This segment is also expected to register the highest CAGR during the forecast period. Growth in this market is mainly driven by the various advantages associated with coated catheters, such as easier, more comfortable insertion, low risk of catheter-associated urinary tract infection, reduced risk of urethral damage, and improved patient satisfaction.

Regional Analysis: -

The market is segmented into four major regions—North America, EuropeAsia Pacific, and the Rest of the World (RoW). North America was the largest regional market for urinary catheters in 2019. The large share of North America in this market can be attributed to the favorable reimbursement scenario and the rising volume of surgeries in the region. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The high growth in this market can be attributed to the growing healthcare spending in emerging Asian countries, rising prevalence of urinary incontinence, and the large target patient population in the region.

Inquiry Before Buying:- https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=132934629

Top Key Players:-

The global urinary catheters market is highly consolidated. The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US). Other players include Asid Bonz GmbH (Germany), Degania Silicone Ltd. (Israel), Bactiguard (Sweden), Medical Technologies of Georgia (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Go Medical Industries Pty Ltd. (Australia), Cure Medical, LLC, Amsino International, Inc. (US), Urocare Products, Inc. (US), J and M Urinary Catheters LLC. (US), CompactCath (US), Hunter Urology (England), MANFRED SAUER GMBH (Germany), and Ribbel International Limited (India).

Tuesday, November 28, 2023

Revolutionizing Surgery: Exploring the Global Surgical Robots Market

 The surgical robots market refers to the industry and market segment focused on robotic systems designed for use in surgical procedures. Surgical robots are advanced medical devices that assist surgeons in performing complex surgical procedures with enhanced precision, control, and flexibility.

The report Surgical Robots Market is projected to reach USD 18.4 billion by 2027 from an estimated USD 8.5 billion in 2022, at a CAGR of 16.6% during the forecast period.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532

Surgical Robots Market Dynamics:

Drivers:

  1. Advantages of robotic-assisted surgery
  2. Technological advancements
  3. Improving reimbursement scenario
  4. Increasing adoption of surgical robots
  5. Increase in funding for medical robot research

Opportunities:

  1. Increasing penetration of surgical robots in ASCs

Market Segmentation: -

·         By product & service, the surgical robots market has been segmented into robotic systems, instruments & accessories, and services. In 2021, the robotic systems segment accounted for the second largest share of the surgical robots market.

·         By robotic systems, the surgical robots market has been segmented into laparoscopy robotic systems, orthopedic robotic systems, neurosurgical robotic systems, and other systems.

·         By application, the surgical robots market has been segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications. The general surgery segment is projected to register the highest growth during the forecast period.

·         Based on end users, the market has been segmented into hospitals & clinics and ambulatory surgery centers. In 2021, the hospitals & clinics accounted for the largest share of the market.

Key Applications of Surgical Robots:

·         General Surgery: Surgical robots are used in various general surgical procedures such as cholecystectomy (gallbladder removal) and hernia repair.

·         Cardiovascular Surgery: They play a role in cardiac procedures like mitral valve repair and coronary artery bypass grafting.

·         Orthopedic Surgery: Surgical robots assist in joint replacement surgeries like knee and hip replacements.

·         Urological Surgery: They are used in procedures like prostatectomy and nephrectomy.

·         Gynecological Surgery: Surgical robots are employed in hysterectomy and other gynecological procedures.

Regional Analysis:

Europe is another prominent region in the surgical robots market. Countries such as Germany, the United Kingdom, France, and Italy have been key players in this market. The region has a well-established healthcare system, high awareness about robotic technologies, and favorable reimbursement policies, which have contributed to the growth of the market.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=256618532

Recent Developments:

  • In 2022, BGS Beta-Gamma-Service GmbH & Co. KG expanded its laboratory in Wiehl to meet the increased need for sterilization services in the sectors of biotechnology, medicine, and diagnostics for radiation cross-linking.
  • In 2022, Sterigenics expanded its electron beam facility located in Columbia city, Indiana. This facility provides mission-critical E-beam sterilization services to help ensure the safety of medical devices and drug products.
  • In 2021, STERIS acquired Cantel, which is a provider of infection prevention services, and this acquisition will strengthen the STERIS leadership in infection prevention by bringing together two complementary businesses.

Top Key Players:-

Intuitive Surgical (US), Stryker Corporation (US), Medtronic Plc (Ireland), Smith & Nephew (UK), Zimmer Biomet (US), Asensus Surgical (US), Siemens Healthineers (Germany), CMR Surgical (UK), Johnson & Johnson (US), and Renishaw Plc. (UK) are key players in the surgical robots market.

It's important to note that the surgical robots market is dynamic and evolving, with ongoing research and development leading to the introduction of new technologies and applications. Regional market dynamics can vary based on factors such as healthcare infrastructure, reimbursement policies, and regulatory environment.

 

Monday, November 27, 2023

Revolutionizing Healthcare: The Potential of Stem Cell Therapy

 Key drivers of the stem cell therapy market include increase in stem cell research funding, expanding number of clinical trials related to stem cell therapies, and growing number of GMP-certified cell therapy production facilities. However, high costs associated with the development of stem cell therapy along with the ethical concerns related to embryonic stem cells are likely to hamper the market growth to a certain extent.

Stem Cell Therapy Market is projected to reach USD 558 million by 2027 from USD 257 million in 2022, at a CAGR of 16.8% during the forecast period, according to a new report by MarketsandMarkets™. 

Browse in-depth TOC on "Stem Cell Therapy Market" 
155 – Tables 
43 – Figures 
166 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48

KEY MARKET DYNAMICS

         1 DRIVERS

                   1 Availability of funding for stem cell research

                   2 Increasing GMP certification approvals for cell therapy production facilities

                   3 Increasing clinical trials for stem cell-based therapies

         2 RESTRAINTS

                   1 Ethical concerns related to embryonic stem cells

                   2 High cost of cell-based research

         3 OPPORTUNITIES

                    1 Emergence of iPSCs as an alternative to ESCs

                    2 Growing demand for cell & gene therapies

         4 CHALLENGES

                    1 Technical limitations associated with manufacturing processes

Market Segmentation

The global stem cell therapy market is segmented into adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placenta/umbilical cord-derived MSCs, and other cell sources.

Based on therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and other therapeutic applications.

Request For 10% Customization:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=48

Regional Analysis

The Asia Pacific region is estimated to grow at the highest CAGR in the stem cell therapy market during the forecast period. Japan and South Korea are the key revenue contributors of the Asia Pacific stem cell therapy market. Favorable government support for product approvals and the presence of major players in these countries are anticipated to drive the regional market growth.

Recent Developments:

  • In July 2022, CORESTEM (South Korea) continued enrolling participants for the Phase 3 clinical trial of NeuroNata-R. This therapy has received conditional approval for treating ALS patients in South Korea
  • In September 2020, Stemedica Cell Technologies received investigational new drug (IND) approval from the US FDA for intravenous allogeneic mesenchymal stem cells (MSCs) to treat moderate to severe COVID-19.
  • In August 2020, Pluristem Israel) collaborated with Abu Dhabi Stem Cells Center (UAE) to develop stem cell therapies for COVID-19 treatment.

Top Key Players:

The stem cell therapy market is consolidated in nature with prominent players in the stem cell therapy market include Smith+Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), CORESTEM (South Korea), Pharmicell Co., Ltd. (South Korea), NuVasive, Inc. (US), RTI Surgical (US), AlloSource (US), JCR Pharmaceuticals Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), Holostem Terapie Avanzate Srl (Italy), Orthofix (US), Regrow Biosciences Pvt Ltd. (India), and STEMPEUTICS RESEARCH PVT LTD. (India).

 

 

Breast Biopsy Devices: Empowering Early Detection and Treatment

  The major factors driving the growth of Breast Biopsy Devices Market include the growing prevalent cases of breast cancer, the increasing ...